RecruitingNCT04669886
Serum Endotoxin Assay to Predict the Development of Postoperative Infectious Complications and Systemic Inflammatory Response Following Percutaneous Nephrolithotomy.
Sponsor
University of Miami
Enrollment
150 participants
Start Date
Nov 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of the study is to establish an infectious risk stratification system based on pre-and post-operative blood endotoxin profile.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with nephrolithiasis and urosepsis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04669886
Related Trials
O. Formigenes Colonization in Calcium Oxalate Kidney Stone Disease
NCT063302462 locations
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
NCT063315462 locations
Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease
NCT069893202 locations
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
NCT065766611 location
HoYAG vs TFL in miniPCNL With ClearPetra
NCT070879771 location